CVS Health Expands Access to Affordable Fertility Treatments Nationwide
CVS Health (NYSE: CVS) has announced a major step toward improving access to fertility care and making fertility treatments more affordable for Americans. Through its CVS Specialty Pharmacy network and more than 9,000 community pharmacy locations, the company is introducing a new initiative designed to simplify the process of obtaining fertility medications while reducing costs for patients and families seeking reproductive assistance.
At the core of this initiative, CVS Specialty Pharmacy will serve as a key partner in the new TrumpRx Fertility program, a national effort aimed at lowering drug prices for essential fertility treatments. The program, established as part of the Trump Administration’s broader strategy to promote competitive pricing across critical therapeutic areas, includes a collaboration with EMD Serono, the manufacturer of Gonal-F, a leading in-vitro fertilization (IVF) drug. Under this partnership, the price of Gonal-F will be reduced by an impressive 84%, marking a significant breakthrough in affordability for patients undergoing fertility treatments.
Lucille Accetta, RPh, Senior Vice President and Chief Pharmacy Officer at CVS Health, emphasized the company’s mission to make healthcare more accessible and patient-centered.
“Fertility medications often require special administration and high-touch expertise,” Accetta said. “We are proud to join the President in making every step of the fertility journey as simple as possible for families by providing nationwide access. Our goal is to continually improve affordability and ensure every patient can obtain the care they need.”
Accetta added that CVS Health’s integrated infrastructure—spanning specialty pharmacy services, clinical expertise, and a vast retail footprint—positions the company uniquely to deliver on this promise. “As the Administration looks to provide more affordable fertility treatments to all Americans, CVS Specialty has both the experience in fertility care and the strong industry relationships needed to make the TrumpRx solution successful,” she said.
Expanding Affordability and Access Across the U.S.
CVS Health’s new fertility initiative reflects its broader strategy to expand affordability through its pharmacy network and diversified healthcare services. The company has consistently used its strengths—such as its large physical footprint and digital platforms—to enhance patient access to critical therapies, as demonstrated in its recent efforts to improve availability and affordability of GLP-1 drugs for diabetes and weight management.
Through this program, CVS Health aims to eliminate one of the biggest barriers faced by individuals pursuing fertility treatment: the high and unpredictable cost of medications. The TrumpRx Fertility program is expected to become available in January 2026, and further details about how patients can access discounted fertility drugs will be shared as the launch approaches.
What Patients Can Expect
Initially, Gonal-F will be the primary drug available at a reduced price through the TrumpRx Fertility platform. However, CVS Health indicated that additional medications and manufacturer partnerships could be introduced as the program evolves before its 2026 debut.
One of the program’s key benefits is the ability to provide patients with transparent pricing and faster access to IVF medications—critical factors in fertility cycles that are often time-sensitive. Patients will no longer need to spend time comparing prices across different pharmacies; instead, they can access a consistent, competitive rate for Gonal-F directly through the TrumpRx Fertility network.
How CVS Specialty Pharmacy Supports Families
CVS Specialty Pharmacy has long been recognized for its dedicated fertility services, offering patients a personalized, supportive experience throughout their treatment journey. The pharmacy’s team of specialist pharmacists, nurses, and support staff are trained to handle the complex needs of fertility medications and provide ongoing guidance to ensure patients use them safely and effectively.
Some of the key services offered by CVS Specialty Pharmacy include:
- Complimentary pre-verification: CVS reviews a patient’s treatment plan to confirm medication coverage before therapy begins, ensuring patients and physicians can make informed financial decisions.
- Financial assistance: For patients without fertility medication benefits, CVS helps determine eligibility for immediate savings programs.
- Insurance and claims support: The pharmacy handles insurance claims and helps patients maximize their coverage while minimizing out-of-pocket costs.
- Expert clinical support: Pharmacists provide education on therapy usage, injection techniques, and managing potential side effects, while coordinating closely with prescribing doctors.
- Comprehensive care coordination: CVS works alongside physicians and fertility clinics to ensure seamless care transitions, including support for egg donor medication needs.
CVS Health’s approach goes beyond simply dispensing medication. Each patient is assigned a pharmacist-led CareTeam, which offers around-the-clock support to address questions, monitor treatment progress, and provide ongoing guidance throughout the fertility process.
Flexible Access and Nationwide Delivery
Unlike most specialty pharmacies that rely solely on delivery, CVS Specialty offers unparalleled flexibility. Patients can choose to pick up fertility medications at any of CVS’s 9,000 pharmacy locations or have them delivered directly to their homes, clinics, or even temporary addresses while traveling.
Delivery is available nationwide with next-day service at no additional cost, ensuring patients receive their medications promptly and securely. All deliveries are shipped in discreet, temperature-controlled packaging to maintain medication integrity and patient privacy.
This flexible access model aligns with CVS Health’s commitment to convenience and patient-centered care. By offering both in-store pickup and reliable home delivery, the company ensures that patients undergoing fertility treatment can focus on their health and family goals rather than logistical challenges.
A Step Forward for Fertility Care in America
The introduction of the TrumpRx Fertility program marks a pivotal moment for reproductive healthcare in the United States. Fertility treatments, especially IVF, can be emotionally and financially taxing. With costs for fertility drugs often running into thousands of dollars per cycle, many families are unable to pursue or complete treatment due to cost constraints.
By partnering with the federal government and manufacturers like EMD Serono, CVS Health is helping bridge that gap—bringing transparency, affordability, and accessibility to a sector that has long needed reform. The 84% reduction in Gonal-F pricing represents not only a milestone for affordability but also a significant step forward in promoting equitable access to family-building care.
As CVS Health continues to expand its fertility and women’s health offerings, this collaboration underscores its broader mission: to be America’s most trusted healthcare partner, committed to simplifying healthcare, improving outcomes, and reducing costs for all.
With this initiative, CVS Health is not just delivering medication—it is helping deliver hope to countless families across the nation.
